Startseite Kongressberichte 2020 All-Virtual 62nd ASH Annual Meeting and Exposition Oral Sessions Acute Myeloid Leukemia AML - Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis I

617. Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis: Single Cell Profiling and Novel molecular Markers

Watch Session

30 Single Cell Transcriptomics Revealed AML and Non-AML Cell Clusters Relevant to Relapse and Remission in Pediatric AML

Beena E Thomas, Pruthvi Perumalla, Swati S Bhasin, et al.

 

31 Identification of Chemo-Resistant Residual Cell Population in Pediatric AML of Complete Remission By Single Cell RNA Sequencing

Shuting Jiang, Fuhong He, Li Gao, et al.

 

32 High-Dimensional Single-Cell Proteomic Analysis Reveals Therapeutic Vulnerabilities in Relapsed/Refractory AML By Concomitant Analysis of Cell Surface Antigens, Signaling Pathways and Anti-Apoptotic Proteins

Muharrem Muftuoglu, Zoe Alaniz, Duncan Mak, et al.

 

33 An Immune Senescence and Exhaustion-Related RNA Profile Predicts Clinical Outcomes in Acute Myeloid Leukemia

Jayakumar Vadakekolathu, Tung On Yau, Heidi Altmann, et al.

 

34 The Application of Machine Learning to Improve the Subclassification and Prognostication of Acute Myeloid Leukemia

Hassan Awada, Arda Durmaz, Carmel Gurnari, et al.

 

35 KRAS mutations Frequently Coexist with High-Risk MLL Fusions and Are Independent Adverse Prognostic Factors in MLL-Rearranged Acute Myeloid Leukemia

Hidemasa Matsuo, Kenichi Yoshida, Kana Nakatani, et al.